Canada's evolving market for biosimilars and what it means for payers = L'évolution du marché des biosimilaires au Canada et ce qu'elle signifie pour les payeurs / Yvonne Zhang.: H82-64/2025-PDF
"Potential savings from biosimilars are a topic of international interest with particular relevance for Canada. Given its high-use and high-price market for biologics, increased biosimilar adoption offers a significant opportunity for cost savings for Canadian payers. Biosimilar switching policies are expected to accelerate cost reductions for biologics in Canada, helping to offset the pressure from new higher-cost medicines. This analysis aims to identify opportunities in the Canadian biosimilar market in comparison with international practices"--Objective.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.965450&sl=0
| Department/Agency |
|
|---|---|
| Title | Canada's evolving market for biosimilars and what it means for payers = L'évolution du marché des biosimilaires au Canada et ce qu'elle signifie pour les payeurs / Yvonne Zhang. |
| Variant title |
|
| Publication type | Monograph |
| Language | Bilingual-[English | French] |
| Format | Digital text |
| Electronic document | |
| Parallel description | [French] |
| Note(s) |
|
| Publishing information |
|
| Author / Contributor |
|
| Description | 1 online resource (1 page) : colour illustrations |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: